Metraipolis › archive › dc_8d833657ed32

An antibody-PROTAC conjugate targets BRD4/c-Myc/PD-L1 to enhance immunotherapy efficacy in triple-negative breast cancer — Europe PMC PMID:42526440

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42526440
DOI
10.1016/j.xcrm.2026.102948
License (as archived)
solo-consultazione
Archived
2026-10-17T10:50:26.471Z
SHA-256 of the archived text
b0164a90cf89d86a054249746db2fbe73494f26c3b674a4bdbb38f6bbeb68543
Stable URL of this page
https://metraipolis.com/documento/dc_8d833657ed32

How to cite

An antibody-PROTAC conjugate targets BRD4/c-Myc/PD-L1 to enhance immunotherapy efficacy in triple-negative breast cancer — Europe PMC PMID:42526440 — Europe PMC (en), https://europepmc.org/article/MED/42526440 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8d833657ed32 (Metraipolis archive dc_8d833657ed32, sha256 b0164a90cf89d86a054249746db2fbe73494f26c3b674a4bdbb38f6bbeb68543)
BibTeX
@misc{dc8d833657ed32,
  title = {An antibody-PROTAC conjugate targets BRD4/c-Myc/PD-L1 to enhance immunotherapy efficacy in triple-negative breast cancer — Europe PMC PMID:42526440},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42526440},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8d833657ed32; sha256 b0164a90cf89d86a054249746db2fbe73494f26c3b674a4bdbb38f6bbeb68543},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42526440. Agents can read the archived copy with the MCP tool read_document.